Please assess the completion status of the following clinical trial:

Trial Title: Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with coronary disease undergoing PCI.~2. At most 2 months since last episode of ST-elevation myocardial infarction.~3. Left ventricular ejection fraction \>=20% \<=45% based on coronary angiography or echocardiography.~Exclusion Criteria:~Any one of the following exclusion criteria is sufficient to disqualify a patient from the study.~1. Patients with non-ST-elevation myocardial infarction.~2. Patients with normal left ventricular function.~3. Patients with mechanical complications of myocardial infarction.~4. Patients with a malignant tumor.~5. Patients with infection disease.~6. Less than 6 months since last episode of stroke.~7. Patients with hematological disease (leukemia, myeloproliferative disease, or myelodysplastic syndromes).~8. AST (GOT) exceeding 100 IU/L or ALT (GPT) exceeding 100 IU/L.~9. Leukocytes less than 4,000/µL or exceeding 10,000/µL.~10. Platelets less than 100,000/µL.~11. Hemoglobin less than 10 g/dL.~12. Pregnant or nursing patients, those who may be pregnant, or those who plan on becoming pregnant before the end of the study period.~13. Any other reason that the Clinical Supervisors or Clinical Researchers may have for considering a case unsuitable for the study.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: SHAM_COMPARATOR): Atorvastatin routine dose
- Intensive Atorvastatin (Type: PLACEBO_COMPARATOR): Atorvastatin Intensive dose
- Atorvastatin+Transplantation (Type: ACTIVE_COMPARATOR): Atorvastatin routine dose+ Mononuclear cells Transplantation
- Intensive Atorvastatin+Transplantation (Type: EXPERIMENTAL): Atorvastatin intensive dose+ Mononuclear cells Transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).